References

Andersson AE, Bergh I, Karlsson J, Nilsson K. Patients' experiences of acquiring a deep surgical site infection: an interview study. Am J Infect Control. 2010; 38:(9)711-717 https://doi.org/10.1016/j.ajic.2010.03.017

Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017; 96:(1)1-15 https://doi.org/10.1016/j.jhin.2017.03.004

Centers for Disease Control and Prevention. CDC/NHSN surveillance definitions for specific types of infections. https://tinyurl.com/yxu2f85t (accessed 24 July 2019)

Downie F. NICE clinical guideline: prevention and treatment of SSIs—is it enough?.: Wounds UK; 2010

Gottrup F, Melling A, Hollander DA. An overview of surgical site infections: aetiology, incidence and risk factors. European Wound Management Association Journal. 2005; 5:(2)11-15

Gould D. Causes, prevention and management of surgical site infection. Nurs Stand. 2012; 26:(47)47-56 https://doi.org/10.7748/ns2012.07.26.47.47.c9226

Gregory KE, Radovinsky L. Research strategies that result in optimal data collection from the patient medical record. Appl Nurs Res. 2012; 25:(2)108-116 https://doi.org/10.1016/j.apnr.2010.02.004

Harrington P. Prevention of surgical site infection. Nurs Stand. 2014; 28:(48)50-58 https://doi.org/10.7748/ns.28.48.50.e8958

Keast D, Swanson T. Ten top tips: managing surgical site infections. Wounds International. 2014; 5:(3)13-18

Korol E, Johnston K, Waser N A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS ONE. 2013; 8:(12) https://doi.org/10.1371/journal.pone.0083743

Martin ET, Kaye KS, Knott C Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016; 37:(1)88-99 https://doi.org/10.1017/ice.2015.249

Identifying surgical site infection in wounds healing by primary intention. 2005. https://tinyurl.com/y4ye6hjs (accessed 29 July 2019)

National Institute for Health and Care Excellence. Surgical site infections: prevention and treatment. NICE guideline NG125. 2019. https://www.nice.org.uk/guidance/ng125 (accessed 24 July 2019)

Petherick ES, Dalton JE, Moore PJ, Cullum N. Methods for identifying surgical wound infection after discharge from hospital: a systematic review. BMC Infect Dis. 2006; 6 https://doi.org/10.1186/1471-2334-6-170

Public Health England. Surveillance of surgical site infections in NHS hospitals in England, 2017 to 2018. 2018. https://tinyurl.com/y6acp75o (accessed 31 July 2019)

Rochon M, Makhecha S, Morais C Quality improvement approach to reducing readmission for surgical site infection. Wounds UK. 2016; 12:(2)26-31

Sanger PC, Hartzler A, Han SM Patient perspectives on post-discharge surgical site infections: towards a patient-centered mobile health solution. PLoS One. 2014; 9:(12) https://doi.org/10.1371/journal.pone.0114016

Tanner J, Khan D. Surgical site infection, preoperative body washing and hair removal. J Perioper Pract. 2008; 18:(6) https://doi.org/10.1177/175045890801800602

Tanner J, Padley W, Davey S, Murphy K, Brown B. Patients' experiences of surgical site infection. Journal of Infection Prevention. 2012; 13:(5)164-168 https://doi.org/10.1177/1757177412452677

Welsh L. Wound care evidence, knowledge and education amongst nurses: a semi-systematic literature review. Int Wound J. 2018; 15:(1)53-61 https://doi.org/10.1111/iwj.12822

Wilson J. Surgical site infection: the principles and practice of surveillance. Part 1: Key concepts in the methodology of SSI surveillance. Journal of Infection Prevention. 2013; 14:(1)6-12 https://doi.org/10.1177/1757177412471147

Wilson J. Surgical site infection. Part 2: analysing and interpreting data. Journal of Infection Prevention. 2013; 14:(6)198-202 https://doi.org/10.1177/1757177413507620

Woelber E, Schrick EJ, Gessner BD, Evans HL. Proportion of surgical site infections occurring after hospital discharge: a systematic review. Surg Infect (Larchmt). 2016; 17:(5)510-519 https://doi.org/10.1089/sur.2015.241

Service improvement study to improve care for patients who developed a surgical site infection after discharge

08 August 2019
Volume 28 · Issue 15

Abstract

Background:

many patients develop surgical site infection (SSI) after they have been discharged from hospital. SSI rate is a quality measure intended to support healthcare providers with useful information to improve service and patient outcomes.

Aim:

the purpose of the study was to gain some local insight into current practice and to inform and improve clinical practice for patients who develop SSIs after they have been discharged.

Method:

a quantitative approach was taken, using retrospective data collection and analysis of patient records, of patients reviewed by the tissue viability service after discharge over a 1-year period.

Findings:

a total of 112 patients were included in the study. Of these, 59 were assessed as having developed an SSI, of whom 39 patients presented after discharge. Most of these patients had shorter inpatient stays and many were under the care of community nurses, but referral to the specialist tissue viability service to seek expert advice was often delayed.

Conclusion:

the study has highlighted the potential value of post-discharge surveillance in contributing to more accurate SSI rates, and the importance of patients and community nurses being provided with clear, understandable information to ensure patients receive timely and effective management, which could reduce the severity of, and duration of treatment for, SSIs.

This service improvement study emerged from the experiences of the tissue viability nurses (TVNs) working in the acute care environment, who are referred patients following their discharge from hospital, many of whom presented with a surgical site infection (SSI) and some of whom had inappropriate or delayed assessment or treatment. The study aimed to gain some local insight into current practices and to inform and improve clinical practice for patients who develop SSIs after discharge. Relatively little attention has been given to the amount of SSIs that present following discharge (Woelber, 2016).

Background

An SSI is a wound infection that can develop after a surgical procedure (National Institute for Health and Care Excellence (NICE), 2019). Between 2013 and 2018 the incidence of SSIs following surgery (including readmissions) ranged between 0.5% for knee replacements and 8.7% for large bowel surgery, with coronary artery bypass graft (CABG) having an incidence of 3.5% (Public Health England (PHE), 2018), caused by bacteria multiplying in the wound.

The severity of SSIs varies. The Centers for Disease Control and Prevention (CDC) (2019) has defined three surgical site infection groups: superficial, deep incisional and organ-space SSIs (see Table 1). Only infections that develop within 30 days of surgery are classed as SSIs; however, this is extended to up to 1 year if the surgery involved implants. Wound infections can develop after surgery, but many are considered to have developed at the time the patient is in surgery, although these individuals may not develop any local or systemic signs of infection until after they have left hospital (NICE, 2019).


Superficial incisional SSI Deep incisional SSI
Must meet the following 2 criteria:
  • Occurs within 30 days of procedure
  • Involves only the skin or subcutaneous tissue around the incision
  • Plus at least 1 of the following criteria:
  • Purulent drainage from the incision
  • Organisms isolated from an aseptically obtained culture of fluid or tissue from the incision
  • At least one of the following signs or symptoms of infection—pain or tenderness, localised swelling, redness or heat—and the incision has been deliberately opened by a surgeon, unless the culture is negative
  • Diagnosis of superficial incisional SSI by a surgeon or attending physician
  • Must meet the following 3 criteria:
  • Occurs within 30 days of procedure (or 1 year in the case of implants)
  • Is related to the procedure
  • Involves deep soft tissues, such as the fascia and muscles
  • Plus at least 1 of the following criteria:
  • Purulent drainage from the incision, but not from the organ space of the surgical site
  • A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms—fever (>38°C), localised pain or tenderness—unless the culture is negative
  • An abscess or other evidence of infection involving the incision is found on direct examination, or by histopathological or radiological examination
  • Diagnosis of a deep incisional SSI by a surgeon or attending physician
  • The following are not considered superficial SSIs Organ-space SSIs
  • Stitch abscesses (minimal inflammation and discharge confined to the points of suture penetration)
  • Infection of an episiotomy or neonatal circumcision site
  • Infected burn wounds
  • Incisional SSIs that extend into the fascial and muscle layers (see Deep SSIs)
  • Must meet the following 2 criteria:
  • Infection occurs within 30 days after the operation if no implant is left in place, or within 1 year if an implant is in place
  • The infection appears to be related to the operation and infection involves any part of the anatomy (eg organs and spaces), other than the incision that was opened or manipulated during an operation
  • Plus at least one of the following:
  • Purulent drainage from a drain that is placed through a stab wound into the organ space
  • Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ space
  • An abscess or other evidence of infection involving the organ space that is found on direct examination, during reoperation, or by histopathological or radiological examination
  • Diagnosis of organ-space SSI made by a surgeon or attending physician
  • Source: Centers for Disease Control and Prevention, 2019

    Superficial infections are often easily treated with a short course of antibiotics. In cardiac surgery, superficial sternal wound infections often cause the patient some pain and discomfort, but they are likely to resolve in a short period with appropriate management, such as topical wound dressings and antibiotics. However, deeper sternal wound infections can cause serious morbidity and mortality, as well as bring significant financial costs to the health service (Gould, 2012).

    Badia et al (2017) highlighted the economic burden caused by SSIs. They can result in extended hospital stays for patients or readmission to hospital. They require additional treatments, all with associated costs to the NHS; in addition, there will be costs for the patient related to their quality of life, increase in pain and a negative psychological and emotional impact (Tanner et al, 2012). Gottrup et al (2005) referred to SSIs as a burden for patients in terms of morbidity and mortality, and for health services in terms of the financial costs incurred. NICE (2019) has stated, due to the advances made in surgery and anaesthesia, more patients who are at higher risk of developing SSIs are today being offered surgery. With a greater number of high-risk individuals undergoing procedures there is, arguably, a need for more monitoring of such patients postoperatively and post discharge.

    SSI surveillance

    The aim of SSI surveillance is to provide accurate SSI rates that can be used to optimise and continuously improve the quality of patient care (Harrington, 2014). It can enable proactive and early interventions, reducing what is often considered to be a preventable harm to patients.

    Local trust surveillance process

    At Liverpool Heart and Chest NHS Foundation Trust, the infection prevention nurses collect and monitor SSI data relating to inpatients and readmissions, and use microbiology (laboratory) results to prompt review of additional patient records. The TVNs contribute to the data when patients are under their care, including those who are seen only after hospital discharge, by adding their details to a shared database of patients who have developed an SSI.

    Prevalence of post-discharge SSI

    Petherick et al (2006) described a global trend regarding shorter inpatient stays for surgical patients and more daycase surgery, meaning that more SSIs are likely to present after the patient has been discharged. More recently, Woelber et al (2016) conducted a systematic review of SSIs that develop after discharge. The review included 55 articles from 15 countries and estimated that post-discharge SSIs account for up to 60% of all SSIs. It is argued by Wilson (2013a) that planned, prospective surveillance will identify additional SSIs that would not otherwise be captured, thereby providing a more accurate SSI rate; active methods of surveillance would also ensure systematic and consistent data collection. However, for this type of surveillance to be undertaken, organisations need to ensure that they allocate appropriate resources. Where it is an additional role for clinical staff with other responsibilities, for example, infection prevention nurses, passive surveillance (using retrospective data from medical records) is more likely to occur, resulting in incomplete and inaccurate SSI rates (Wilson, 2013a).

    Ethical considerations

    Although the study involved no direct patient contact, it involved processing personal data from the electronic patient records (EPR). Data protection and confidentiality practices were maintained. Permission was gained from the organisation.

    Methods

    A quantitative approach was used. Retrospective data collection from the EPR of all patients who had been seen in the tissue viability service wound clinic after discharge between 1 April 2017 and 31 March 2018 was used to determine how many individuals had an SSI, as well as patient demographics and other relevant data, as detailed in the collection form.

    To retrieve reliable data, Gregory and Radovinsky (2012) stressed the importance of using a reliable and tested data collection form, and the use of a code book to guide the data abstractors. For this study, a pilot test was completed on a sample of 5 patients, which identified improvements to the form, ensuring easier and more effective data collection. It established the content validity of the data collection tool, and improved the data being collected, the scales used and its overall format. It tested inter-rater reliability, to establish that all 3 data abstractors were retrieving data consistently. A code book (Box 1) was developed specifically for the study, which was also tested, and changes made during the pilot. The code book included each item on the data collection form, a definition of what each means in this study, and the best source of data within the patient record.

    Code Book

    Study identification number

    Identification number assigned just for the purposes of the study, take from list of patients included in the study numbered 1–131

    Data abstractor: Record the name of the person who is completing the data collection form

    Date: Record the date the data is being collected

    Data entered: Record the date the data is entered on to Excel and will be used after all data collection forms have been completed

    1. Patient identification (CT number)

    Definition: Unique patient identifier specific to the hospital

    Best source: Appropriate section of the electronic patient record (EPR)

    2. Patient full name

    Definition: First and last name as recorded in patient record

    Best source: EPR

    3. Is the patient being seen by the tissue viability nurse for a surgical wound?

    Definition: Self-explanatory

    Best source: Record in EPR. If the answer is ‘‘no’, only complete 12 (tick ‘other’), then provide details elsewhere

    4. Gender

    Definition: Either of the two sexes, male or female

    Best source: EPR

    5. Age

    Definition: Self-explanatory, patient's age in years at time of surgery

    Best source: EPR

    6. Body mass index

    Definition: Body mass index (BMI) measure of body fat based on height and weight that applies to adult men and women; at time of surgery. High BMI is a significant risk factor for surgical site infection in patients following cardiac surgery

    Best source: EPR or, if not recorded there, identify on other records

    7. Diabetes

    Definition: Serious lifelong health condition that occurs when the amount of glucose (sugar) in the blood is too high because the body cannot use it properly. If left untreated, high blood glucose levels can cause serious health complications. It is a significant risk factor for surgical site infection in patients following cardiac surgery

    Best source: EPR

    8. Date of surgery

    Definition: Date of surgery for this episode of care

    Best source: EPR

    9. Surgery

    Definition: Surgical procedure or operation performed in theatre for this episode of care

    Best source: EPR, will be included in discharge summary

    10. Date of discharge

    Definition: The date the patient was discharged from the hospital (the last episode of care)

    Best source: EPR

    11. Date 1st seen in wound clinic by tissue viability service

    Definition: Self-explanatory

    Best source: EPR, look for first entry by tissue viability nurse after discharge date (identified above)

    12. Type of wound

    Definition: Refers to the type of wound involved, such as sternal wound, donor leg wound, pacemaker site

    Best source: EPR, first entry by tissue viability nurse after discharge date

    14. Evidence of surgical site (wound) infection (within 30 days of surgery)

    Definition: Self-explanatory, as per definitions of SSI

    Best source: EPR, first entry by tissue viability nurse after discharge date. Then use date of surgery and earliest date that has been identified when wound showed signs of infection or if antibiotics have been prescribed for wound infection

    15. Description of wound and treatment required

    Definition: Clinical assessment of wound and agreed treatment (include topical wound management, debridement, antibiotic therapy, admission, etc)

    Best source: EPR, look for first entry by TVN after discharge date

    16. Referred by:

    Definition: The person referring the patient to the tissue viability service for review

    Best source: EPR, first entry by TVN after discharge date. If not recorded, check Outlook/emails, using patient name as search term

    17. Involvement by community nurses

    Definition: Community nurses have been involved in the patient's care (wound management) after discharge from hospital

    Best source: EPR, first entry by TVN after discharge date

    18. GP Address

    Definition: Address of patient's GP surgery or practice

    Best source: EPR

    Community trust

    Definition: Providers of community health and social care services

    Best source:

    The data were entered onto Microsoft Excel and analysed using the SPSSv25 statistical software package.

    Results and data analysis

    The study population was drawn from 112 patients who had been reviewed by the tissue viability service in the wound clinic: 77 were new patients referred to the service after discharge and 32 whose care continued after discharge (3 patients were excluded because they did not have a surgical wound) (Figure 1). Of these, 59 patients developed SSIs (within 30 days of surgery). This is the group discussed further in this article.

    Figure 1. Cohort diagram of study population

    Some patients' wounds had already presented with delayed healing, dehiscence and/or infection before discharge, and were already under the care of the TVNs (n=32/112; 28.6%), so their management continued in the wound clinic in the outpatient department after they were discharged. The remaining 77 were referred to the service after discharge as follows:

  • 17 (15.2%) were referred when they attended planned routine hospital follow up with the consultant or registrar
  • 20 (17.9%) patients referred themselves
  • 9 (8%) were referred by district nurses
  • 6 (5.4%) by their GP
  • 17 (15.2%) by the medical team (this information was not specific, so may include hospital doctors or doctors in the community)
  • 2 (1.8%) were referred by the cardiac rehabilitation nurse
  • This information was not recorded for the remainder of patients.
  • Most of the 112 patients (n=86; 76.8%) who were seen post discharge had undergone coronary artery bypass graft (CABG) surgery, CABG plus valve surgery, or valve surgery alone. A smaller number had wounds relating to thoracic surgery or pacemaker sites (n=5; 4.5%); and a further group had ‘other’ wounds related to rewiring, removal of sternal wires and surgical debridement (n=11; 9.8%).

    The most frequently seen wounds were sternal (n=69/112; 62%) with the next most frequent being donor leg wounds (n=28/112; 25%); the latter is created when the long saphenous vein is harvested for use in CABG surgery. Other patients had thoracotomy wounds (n=2/112; 2%) and a further group had wounds relating to drain sites, groin wounds and other procedures (n=11/112; 10%). For 2 (1.8%) patients, the wound type was not recorded.

    Of the 112 patients who were reviewed by the tissue viability service in clinic after discharge, 29 (25.9%) patients had no infection, and this information was not recorded for 5 patients. A total of 59 patients were considered eligible for inclusion in the study as having developed an SSI (ie within 30 days of the date of surgery). The TVNs determined that 31 patients had not developed an SSI, in 17 cases it was not possible to determine whether there was an infection or not, and for 5 patients this information was not recorded. The missing data may have been because the nurse had not asked the patient during the consultation, had not recorded it in the patient record, or the patient may have been unable to recall information about the treatment relating to that period.

    Patient demographics

    The demographic information for the 59 patients who were seen post discharge who developed an SSI was as follows:

  • The majority were male: 42 (71%) men versus 17 (29% women)
  • 46 (78%) were aged over 60 years, of whom 24 (41%) were aged over 70 years. A patient's age can be a risk factor in developing wound infections due to lower immune response and slower healing, chronic conditions and medications (Keast and Swanson, 2014)
  • Just under half (28; 47%) had a high BMI, of whom 10 (17%) had a BMI of more than 30 (obese). Of the remainder, 18 (31%) had BMI of 25–29.9 (overweight). Just over half the patients (30; 51%) had a BMI of 18.5-24.9 and for one patient BMI was not recorded. A higher BMI has been shown to increase the likelihood of developing an SSI, particularly among those undergoing cardiac surgery (PHE, 2018)
  • More than half the patients (34; 58%) had diabetes. Patients who have diabetes or where blood glucose is not well controlled are at higher risk of SSI (Martin et al, 2015)
  • 39 (66%) of wounds that developed an SSI were sternal, 17 (29%) were donor leg wounds, with 3 classed as ‘other’.
  • Characteristics such as gender, age, high BMI and diabetes are reported as risk factors for SSIs (Korol, 2017). In the final cohort of 59, more than twice as many men as women who were seen in outpatients had developed an SSI (n=42; 71%, versus n=17; 29%). In Liverpool Heart and Chest NHS Foundation Trust, the gender balance for cardiac surgery is about 70% men and 30% women

    The patients were resident across England and Wales and the Isle of Man. Their post-discharge infections were more likely to be managed or readmitted locally. Consequently, not all patients would have been known to the tissue viability service and therefore would not have been captured within this study or within SSI data.

    Referral and management

    Table 2 shows the route of referral for the 59 patients who were recorded as having developed an SSI: 20 were already known to the tissue viability service and their care continued after discharge and 39 patients were referred to the service after discharge. Of these 39 patients, 15 (25%) had referred themselves; 7 (12%) were referred from follow-up clinic, attending a planned appointment and presenting with wound problems; 12 (20%) were referred by a GP or medical team (14% and 7% respectively). Had these 39 patients not been referred to the TVNs, they may not have been captured in the Trust's SSI data.


    Route of referral Number of patients (%)
    Not recorded 2 (3)
    At planned follow-up appointment 7 (12)
    Continued care by tissue viability nurse 20 (34)
    District nurse 3 (5)
    GP 4 (7)
    Medical team 8 (14)
    Patient 15 (25)
    Total 59 (100)

    Table 3 shows that more than half the patients (n=20; 51%) were under the care of community nurses. It is important that community staff know who to refer back to if wounds fail to progress. The tissue viability service contact details are included in the discharge information provided to patients, but community staff may not be aware of these. Most patients (19/38; 50%) (1 patient was excluded due to insufficient information) continued to have ongoing wound problems 4 weeks after discharge before being referred by a health professional or self-referring for review by the tissue viability service. A recommendation has been made to develop supportive working relationships with community nurses, provide education where needed and improve the quality of patient information provided.


    Number of patients Frequency Percent
    Not recorded 9 23
    No 10 26
    Yes 20 51
    Total 39 100

    In cardiac surgery, 60% of patients develop SSIs within 30 days of surgery. However, the average time for a superficial infection to present is 10 days after surgery and 14 days for a deep or organ-space infection (Rochon et al, 2016). Patients are often in hospital for shorter periods and experience earlier discharges, before such wound infections have had time to develop, and will therefore present when the patient is back in the community (Melling et al, 2005). In this study, 26/39 (67%) of the patients who presented with SSIs after discharge had had an inpatient stay of less than 8 days (Figure 3).

    Figure 3. Length of inpatient stay

    Figure 4 shows the type of interventions and treatments that patients in this review (n=38) received for their wounds and wound infections. These ranged from additional antibiotics and topical wound dressings to wound reopenings, debridement, readmission, intravenous antibiotics and further surgery. Negative pressure wound therapy is often used in the management of surgical wounds that have not followed the normal wound healing process, with or without the presence of infection.

    Figure 4. Analysis of interventions required for patients who developed surgical site infections post discharge

    Discussion and recommendations

    This study has provided local insight into activity in a wound clinic, with a specific focus on patients who developed SSI after discharge. Some patients did not present with signs of wound infection until after they had left hospital. This supports an argument for the Trust to consider participating in some form of post-discharge surveillance. Many of the patients also had an inpatient stay of less than 8 days, which increases the risk of a wound infection presenting after discharge.

    Despite the fact that many patients had community nurse involvement, it was more than 4 weeks before the patient or nurse contacted the hospital for advice. Early diagnosis of an SSI is crucial in ensuring that the patient receives the most effective management (Keast and Swanson, 2014). The tissue viability service would suggest that it needs to receive referrals earlier in the patient's management. However, the information currently provided to patients following surgery does not include a referral pathway with recommended timeframes.

    The study demonstrated that a variety of treatments are required as a result of a patient developing an SSI, highlighting the frequent use of additional interventions to promote wound healing, as part of treatment of an SSI. This not only increases costs, but also has an impact on the patient's quality of life.

    These findings have been used to make recommendations to improve the quality of care for patients who develop an SSI after hospital discharge.

    Recommendations

    Review of the SSI surveillance process in the Trust

    The Trust should consider a review of the current surveillance process, and consider options for future surveillance, including participating in post-discharge surveillance and different methods that could be used, such a such as patient questionnaire or follow-up telephone call. It has been argued that SSIs will be found if they are actively looked for (Downie, 2010), suggesting that passive surveillance misses some. Since up to 70% of SSIs can be identified after discharge there appears to be a strong argument for the Trust to consider participating in post-discharge surveillance.

    Develop supportive working relationships with community nurses and provision of education

    Community nurses are involved in managing several types of wound and many factors can affect wound healing. These issues can make the management of different wounds in the community difficult and challenging.

    Welsh (2018) stated that nurses may have insufficient wound-care knowledge, and follow practices that are sometimes ritualistic and out of date. Appropriate education for community nurses could contribute to improved knowledge and skills in surgical wound management and enable them to recognise early signs of infection, leading them to seek earlier involvement with the tissue viability service.

    It is recommended that the tissue viability service forges closer working relationships with community staff, beginning with the local community Trust and delivers specific training in managing patients with wounds following cardiac surgery.

    Review of patient information provided on discharge

    All patients should be given consistent and understandable information about their wound when they are discharged from hospital. This should include how to care for their wound, recognising signs of an SSI and whom to contact if they have any concerns. Current wound-care patient information is included as part of a cardiac surgery discharge booklet. An additional leaflet is available, but it is not known whether all patients are provided with this; practices seem to vary from ward to ward. Sanger et al (2014) identified gaps in post-discharge care after surgery, which could impact negatively on clinical outcomes and the patient experience and their quality of life.

    It is recommended that the Trust review information provided on discharge to support patients and community staff in recognising potential signs of wound infection and to enable easier access to the tissue viability service.

    Consider implementing a quality improvement strategy such as ‘photo at discharge’

    Andersson et al (2010) argued that a number of strategies can be used to support early diagnosis and treatment of SSIs. These can help improve the patient experience, by preventing or reducing the physical, social, psychological and financial effects that can occur as a result of an SSI.

    One strategy implemented at Harefield Hospital is ‘photo at discharge’ (PaD). Rochon et al (2016) argued that the severity and duration of infection will be reduced if patients seek earlier advice and therefore receive earlier treatment. Providing a photograph of the patient's wound and some additional wound-care information at discharge gives the patient and any future healthcare provider, such as a community nurse or GP, a baseline to aid comparison. The information highlights key signs that could suggest there is a wound infection and provides advice on whom to contact. Rochon et al (2016) reported a significant reduction in readmissions for SSIs and associated costs.

    Limitations

    Although this study has identified some clinically interesting findings, it cannot contribute to meaningful statistical evidence relating to the significance of post-discharge SSIs at the hospital where the study was undertaken. It has demonstrated that a number of patients are presenting with wound infection after discharge, but what is unknown is what the actual numbers are or what proportion of SSIs they are likely to represent.

    Conclusion

    The aim of this study was to provide local insight into activity in TVN-led clinic in outpatients with the aim of improving the service that patients receive if they develop an SSI or wound infection. Retrospective data collection and analysis highlighted that patients who develop an SSI after discharge often ended up having a short inpatient stay. In addition, many patients and community nurses delayed seeking advice from a specialist TVN.

    This study supports other research in demonstrating that many SSIs occur after hospital discharge. They can result in patients requiring additional treatment, including antibiotics, readmission to hospital and even additional surgery: this has consequences both for the patient, in terms of the impact on quality of life and experience, and to the NHS in terms of the financial costs. Downie (2010) questioned whether trusts can with confidence know what their actual SSI rate is because many patients will present after discharge from hospital and may therefore not be captured in reporting data (Tanner and Khan, 2008). Without proactive and accurate collection of SSI data, the true extent of the problem cannot be known, which could be limiting how resources are allocated to preventing SSIs in hospitals. Without complete surveillance data on infection rates (patient outcomes), poorer practice may not be identified and opportunities for making improvements in practice may be missed (Wilson, 2013b).

    Several recommendations have been made. The Trust should consider the value of participating in some type of post-discharge surveillance. This could enable identification of patients experiencing wound-healing problems and instigate prompt assessment by the TVN and/or surgical team, supporting patients in accessing expert advice. Similarly, improving the quality of information provided to patients and community nurses, and developing closer working relationships with community trusts, could lead to prompt review, and to patients receiving earlier and appropriate treatment, which would potentially reduce the severity of infections and the number of readmissions.

    Further research would need to assess the proportion of patients who develop an SSI after discharge. This would require prospective post-discharge surveillance applied in a continuous and consistent way.

    KEY POINTS

  • A surgical site infection (SSI) is a wound infection that can develop after a surgical procedure
  • Patients may not develop any local or systemic signs of infection until after they leave hospital
  • SSIs can result in additional treatments, even readmission to hospital, which incurs financial costs to NHS and costs to the patients in terms of quality of life
  • Without accurate post-discharge surveillance it is not known is how many patients develop SSIs post discharge
  • Post-discharge surveillance could contribute to more accurate SSI rates
  • CPD reflective questions

  • Why are more patients likely to present with surgical site infection (SSI) after discharge from hospital?
  • Identify and reflect on the benefits of post-discharge surveillance
  • Consider which additional resources may be required to participate in post discharge surveillance
  • What strategies could support early diagnosis and treatment of SSIs?